Total Payments
$1,185
2024 Payments
$437.16
Companies
10
Transactions
64
Medicare Patients
377
Medicare Billing
$64,745
Payment Breakdown by Category
Food & Beverage$1,185 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,185 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $920.64 | 47 | $0 (2024) |
| Alkermes, Inc. | $41.81 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $36.50 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $36.08 | 5 | $0 (2017) |
| ITI, Inc. | $36.00 | 2 | $0 (2022) |
| Lundbeck LLC | $33.45 | 2 | $0 (2023) |
| Sage Therapeutics, Inc. | $26.85 | 1 | $0 (2024) |
| Bausch Health US, LLC | $19.83 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $17.92 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $15.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.16 | 18 | ABBVIE INC. ($394.36) |
| 2023 | $186.65 | 11 | AbbVie Inc. ($151.34) |
| 2022 | $512.22 | 29 | ABBVIE INC. ($362.02) |
| 2021 | $12.92 | 1 | AbbVie Inc. ($12.92) |
| 2017 | $36.08 | 5 | Sunovion Pharmaceuticals Inc. ($36.08) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Neuroscience | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 97 | 282 | $48,830 | $18,997 |
| 2022 | 3 | 98 | 263 | $42,960 | $17,599 |
| 2021 | 4 | 97 | 242 | $36,220 | $16,476 |
| 2020 | 3 | 85 | 209 | $30,740 | $11,673 |
Total Patients
377
Total Services
996
Medicare Billing
$64,745
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 129 | $32,250 | $11,315 | 35.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 44 | 137 | $13,700 | $6,712 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 16 | $2,880 | $970.47 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 86 | $21,500 | $8,241 | 38.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 40 | 130 | $13,000 | $6,754 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 47 | $8,460 | $2,604 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 98 | $17,640 | $6,909 | 39.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 33 | 98 | $9,800 | $5,548 | 56.6% |
| 99354 | Prolonged outpatient service, first hour | Office | 2021 | 14 | 21 | $3,780 | $2,055 | 54.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 25 | $5,000 | $1,964 | 39.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 31 | 92 | $9,200 | $4,654 | 50.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 44 | $8,400 | $3,880 | 46.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 73 | $13,140 | $3,139 | 23.9% |
About Dr. Carolyn Sammon, MD
Dr. Carolyn Sammon, MD is a Psychiatry healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124034780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carolyn Sammon, MD has received a total of $1,185 in payments from pharmaceutical and medical device companies, with $437.16 received in 2024. These payments were reported across 64 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,185).
As a Medicare-enrolled provider, Sammon has provided services to 377 Medicare beneficiaries, totaling 996 services with total Medicare billing of $64,745. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Woonsocket, RI
- Active Since 08/01/2006
- Last Updated 03/19/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1124034780
Products in Payments
- VRAYLAR (Drug) $920.64
- AUSTEDO (Drug) $36.50
- LATUDA (Drug) $36.08
- CAPLYTA (Drug) $36.00
- REXULTI (Drug) $33.45
- ZURZUVAE (Drug) $26.85
- LYBALVI (Drug) $24.81
- APLENZIN (Drug) $19.83
- QELBREE (Drug) $17.92
- ARISTADA (Drug) $17.00
- SPRAVATO (Drug) $15.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.